TELTRON

TELTRON Tablets contains Telmisartan. It has very high lipophilicity, a unique feature of telmisartan, coupled with a high volume of distribution, indicate that the compound offers the clinically important advantage of good tissue penetration. Telmisartan is not a prodrug and has a longer terminal elimination half-life than other commercially available sartans (~24 h), making it suitable for once-daily dosing.

 

 


Telmisartan is an angiotensin II receptor antagonist.

TELTRON Tablets can be used in the treatment of the following conditions:

  • Mild to moderate hypertension
  • First line treament in the management of essential hypertension
  • Cardiovascular risk reduction (MI, stroke, elevated lipid profile etc.)


One TELTRON Tablet once daily (with/without food), or as directed by Physician.

Telmisartan interferes with the binding of angiotensin II to the angiotensin II AT1-receptor by binding reversibly and selectively to the receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance.